| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 550,000 | 23 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SYRE | Aeglea BioTherapeutics, Inc. | 23 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 24 Feb 2023, 17:25 |
| SYRE | Aeglea BioTherapeutics, Inc. | 14 Nov 2022 | 1 | $0 | 4 | Chief Medical Officer | 27 Jan 2023, 17:20 |
| SYRE | Aeglea BioTherapeutics, Inc. | 14 Nov 2022 | 0 | $0 | 3 | Chief Medical Officer | 27 Jan 2023, 17:18 |